Just as nephrologists are adept at detecting and managing the hyperkalemia of renin-angiotensin-system (RAS) inhibitors, we will need to master the art of treating the gastrointestinal disorders that are found in over half the recipients of GLP-1s (Figure 9)
However, GLP-1 receptor agonist medications apparently affect these gut-derived reward commands, decreasing both food and alcohol seeking
G protein coupling Comparison of the two tirzepatide- and three peptide 20-bound GPCRG s complex structures with that of other class B1 GPCR family members reveals a high similarity in the G protein binding interface, suggesting a common mechanism for G s engagement 4,33,35,36,37,38 (Fig
BPC-157 blocks amphetamine stereotypy and rescues haloperidol-induced catalepsy BPC-157 is anti-nociceptive in an incisional-pain model but if you need it in a pinch it counteracts morphines analgesia and lithium toxicity BPC-157 corrects basically any electrolyte problem in any direction: hyperkalemia, hypermagnesemia, and honestly you should just read this litany of various electrolyte disturbances that BPC-157 handles with ease BPC-157 reverses both atropine mydriasis and drug-induced miosis in the same rats and guinea pigs